Biomedical Proteomics Facility

Equipment/facility: Facility


Mass spectrometry is one of the leading technologies to comprehensively identify and globally quantify proteins and other biomolecules in virtually every biological sample and environment. Due to its unparalleled sensitivity and accuracy, mass spectrometry is the method of choice for a plethora of applications ranging from biomarker discoveries to absolute quantifications of low abundant peptide species. Equipped with the latest mass spectrometric instrumentation, the Monash Biomedical Proteomics Facility (MBPF) combines cutting-edge technology with state-of-the-art methodology to provide the best possible results and expertise to customers and collaborators.